Evaluating the Diagnostic Performance of BINAX NOW RSV
Author Information
Author(s): Jonathan Nteimam
Primary Institution: Health Protection Agency, Birmingham Heartlands Hospital
Hypothesis
Can BINAX NOW RSV provide reliable diagnostic results for respiratory syncytial virus (RSV) compared to traditional methods?
Conclusion
BINAX NOW RSV can be relied upon for making infection control decisions in pediatric units during peak RSV activity.
Supporting Evidence
- 11% of specimens were positive for RSV by cell culture.
- 23% were positive by direct immunofluorescence.
- 15% were positive by BINAX NOW RSV.
- 19% were considered true positives.
- 81% were true negatives.
Takeaway
The BINAX NOW RSV test helps doctors quickly find out if kids have a virus that makes them sick, especially in winter when many kids get sick.
Methodology
The study tested 100 specimens using BINAX NOW RSV, direct immunofluorescence (DIF), and cell culture to compare their effectiveness in diagnosing RSV.
Limitations
The sensitivity of BINAX NOW RSV was lower than expected, and negative results should be confirmed with another method.
Participant Demographics
The study included infants, children, and adults, with specific age ranges for each group.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website